Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH)

D. Martolini, P. Onorati, G. Valli, A. M. Ferrazza, P. Marinelli, M. Internullo, L. Sardo, C. Gambardella, B. Pezzuto, C. D. Vizza, P. Palange (Rome, Italy)

Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Session: Treatment of human pulmonary hypertension
Session type: Thematic Poster Session
Number: 2286
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Martolini, P. Onorati, G. Valli, A. M. Ferrazza, P. Marinelli, M. Internullo, L. Sardo, C. Gambardella, B. Pezzuto, C. D. Vizza, P. Palange (Rome, Italy). Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH). Eur Respir J 2011; 38: Suppl. 55, 2286

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020


Pulmonary hypertension reduces exercise tolerance in COPD
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010

Pathophysiology of exercise limitation in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005

Effects of mean pulmonary arterial pressure and supplemental oxygen on exercise capacity in IPF patients with exercise-induced hypoxemia
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2017




Acute effects of oxygen supplementation during exercise in patients with pulmonary arterial hypertension
Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Year: 2019



Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


The prevalence of ventilatory limitation at peak exercise in pulmonary arterial hypertension
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014

Effect of dopamine infusion and oxygen supplementation on exercise ventilatory response and endurance in COPD
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005


Epigenetic effects of exercise and respiratory training in patients with pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018



Upper extremity aerobic exercise training improves peak oxygen consumption in patients with pulmonary arterial hypertension
Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients
Year: 2018


Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005

Tadalafil improves exercise capacity and delays time to clinical worsening in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Year: 2008

Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Exercise training in pulmonary hypertension improves muscle efficiency and exercise capacity
Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Year: 2008

Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009


ACE-inhibition improves peak exercise oxygen uptake and ventilation in COPD: an effect unrelated to pulmonary function
Source: Eur Respir J 2003; 22: Suppl. 45, 205s
Year: 2003

Influence of exercise training on cardiac baroreflex sensitivity in patients with COPD
Source: Eur Respir J 2004; 23: 396-401
Year: 2004



Hemodynamics as a substitute for exercise capacity endpoints in patients with pulmonary arterial hypertension (PAH): A model based assessment for sildenafil
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010

Aerobic exercise capacity in COPD patients with and without pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009


Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005